Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Active Communities - Adherence to Physical Activity Among Persons With Type 2 Diabetes, Cardiovascular Disease and/or Obesity - With a Focus on IT as a Tool
NCT number | NCT05493345 |
Other study ID # | 21076311 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | August 5, 2022 |
Est. completion date | August 1, 2024 |
The primary aim of this study is to investigate whether a number of co-created bridge-building activities between municipality-based lifestyle programs and community-based physical activities (e.g. local sports and exercise associations) can support persons with type 2 diabetes, cardiovascular disease and/or obesity in maintain physical activity levels.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | August 1, 2024 |
Est. primary completion date | September 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Citizens in the municipality of Odsherred undergoing a municipality-based lifestyle program - Obese, or diagnosed with type 2 diabetes or cardiovascular disease Exclusion Criteria: - reliant on a wheelchair |
Country | Name | City | State |
---|---|---|---|
Denmark | Centre for Physical Activity Research, Rigshospitalet | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark | Center for Clinical Research and Prevention, Steno Diabetes Center Sjaelland |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility and fidelity | Feasibility and fidelity are evaluated using research progression criteria. Every domain is scored as either 1) Progress to RCT (randomized controlled trial) (green), 2) Amend before progressing to RCT (amber) or 3 do not progress to RCT (red).
Domains include: Satisfaction with project activities Recruitment rate Test- and participation burden Retainment Referral rate Adherence Physical activity improvement |
From baseline (0 months) to follow-up (9 months) | |
Secondary | Moderate and vigorous physical activity (MVPA) time | Change in time spend in MVPA (Accelerometer AX3) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Sitting time | Change in time spend sitting (Accelerometer AX3) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Low-intensity physical activity (LPA) time | Change in time spend in LPA (Accelerometer AX3) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Total physical activity (TPA) level | Change in TPA measured in counts per minute (CPM) (Accelerometer AX3) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Steps | Change in number of steps (Acceleromter AX3) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Six-minute walk distance | Change in distance walked in a period of 6 minutes (6-minute walk test) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Standing balance | Change in time spend in three standing positions (0-30 sec) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Body weight | Change in body weight (bioimpedance scale) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Fat mass | Change in fat mass (bioimpedance scale) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Fat percentage | Change in fat percentage (bioimpedance scale) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Fat free mass | Change in fat free mass (bioimpedance scale) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Muscle mass | Change in muscle mass (bioimpedance scale) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Body mass index | Change in body mass index (BMI) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Mental well-being | Change in 5-item World Health Organization well-being index (WHO-5) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Risk of depression | Change in number of participants scoring <50 in the WHO-5 | From baseline (0 months) to follow-up (9 months) | |
Secondary | Physical health-related quality of life | Change in the SF-12 physical component summary (PCS) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Mental health-related quality of life | Change in the SF-12 mental component summary (MCS) | From baseline (0 months) to follow-up (9 months) | |
Secondary | Perceived stress | Change in perceived stress scale (PSS) score | From baseline (0 months) to follow-up (9 months) | |
Secondary | Loneliness | Change in Three-Item Loneliness Scale (T-ILS) score | From baseline (0 months) to follow-up (9 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |